• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支架置入术与单纯球囊血管成形术治疗膝下病变患者:倾向评分匹配分析。

Stenting versus balloon angioplasty alone in patients with below-the-knee disease: A propensity score-matched analysis.

机构信息

Cardiovascular Center, Konkuk Univesrity Chungju Hospital, Chungju, Korea.

Department of Internal Medicine, Soonchunhyang University Gumi Hospital, Gumi, Korea.

出版信息

PLoS One. 2021 Jun 10;16(6):e0251755. doi: 10.1371/journal.pone.0251755. eCollection 2021.

DOI:10.1371/journal.pone.0251755
PMID:34111147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8191955/
Abstract

Percutaneous transluminal angioplasty (PTA) is considered an effective treatment in patients with critical limb ischemia (CLI). However, the long-term durability of below-the-knee (BTK) PTA is known to be limited. This study sought to compare the 1-year clinical outcomes following stenting versus balloon angioplasty alone in BTK lesions. This study included 357 consecutive patients (400 limbs, 697 lesions) with BTK lesions who underwent PTA from September 2010 to December 2016. All enrolled patients were treated either by stenting (stent group; 111 limbs of 102 patients) or plain old balloon angioplasty (POBA group; 289 limbs of 255 patients). Stent group includes both primary and provisional stenting. Angiographic outcomes, procedural success, complications, and clinical outcomes were compared between the two groups up to 1 year. After propensity score matching (PSM) analysis, 56 pairs were generated, and the baseline and angiographic characteristics were balanced. The procedural success and complications were similar between the two groups; however, the incidence of procedure-related perforation was higher in the POBA group than in the stenting group [5(11.9%) vs.1 (0.9%), P = 0.009]. Six- to 9-month computed tomography or angiographic follow-up showed similar incidences of binary restenosis, primary patency, and secondary patency. In the 1-year clinical follow-up, there were similar incidences of individual hard endpoints, including mortality, myocardial infarction, limb salvage, and amputation rate, with the exception of target extremity revascularization (TER), which tended to be higher in the stenting group than in the POBA group [21 (20.8%) vs. 11 (10.9%), P = 0.054]. Although there was a trend toward a higher incidence of TER risk in the stenting group, stent implantation, particularly in bail-out stenting seemed to have acceptable 1-year safety and efficacy compared to POBA alone in patients undergoing BTK PTA.

摘要

经皮腔内血管成形术(PTA)被认为是治疗严重肢体缺血(CLI)患者的有效方法。然而,已知膝下(BTK)PTA 的长期耐久性有限。本研究旨在比较 BTK 病变中支架置入与单纯球囊血管成形术的 1 年临床疗效。本研究纳入了 2010 年 9 月至 2016 年 12 月期间接受 PTA 的 357 例连续 BTK 病变患者(400 条肢体,697 处病变)。所有入组患者均接受支架置入(支架组;102 例患者的 111 条肢体)或单纯球囊血管成形术(POBA 组;255 例患者的 289 条肢体)治疗。支架组包括直接支架置入和补救性支架置入。比较两组患者至 1 年时的血管造影结果、手术成功率、并发症和临床结局。在倾向评分匹配(PSM)分析后,生成了 56 对,两组的基线和血管造影特征平衡。两组的手术成功率和并发症相似;然而,POBA 组的手术相关穿孔发生率高于支架组[5(11.9%)比 1(0.9%),P=0.009]。6-9 个月的计算机断层扫描或血管造影随访显示,二进制再狭窄、一期通畅率和二期通畅率相似。在 1 年的临床随访中,除了靶肢体血运重建(TER)外,两组患者的个体硬终点发生率相似,包括死亡率、心肌梗死、肢体挽救率和截肢率[21(20.8%)比 11(10.9%),P=0.054]。尽管支架组的 TER 风险发生率有升高趋势,但与单独 POBA 相比,支架置入术,特别是挽救性支架置入术,在 BTK PTA 患者中具有可接受的 1 年安全性和疗效。

相似文献

1
Stenting versus balloon angioplasty alone in patients with below-the-knee disease: A propensity score-matched analysis.支架置入术与单纯球囊血管成形术治疗膝下病变患者:倾向评分匹配分析。
PLoS One. 2021 Jun 10;16(6):e0251755. doi: 10.1371/journal.pone.0251755. eCollection 2021.
2
Randomized clinical trial to compare the efficacy of self-expanding bare metal nitinol stent and balloon angioplasty alone for below-the-knee lesions following successful balloon angioplasty: 1-year clinical outcomes.经球囊血管成形术后成功治疗的膝下病变患者中比较自膨式裸金属镍钛诺支架和单纯球囊血管成形术疗效的随机临床试验:1 年临床结果。
PLoS One. 2023 Nov 13;18(11):e0294132. doi: 10.1371/journal.pone.0294132. eCollection 2023.
3
Six-year multicenter experience of standard endovascular treatment of critical limb ischemia in the era of drug-eluting devices.药物洗脱装置时代严重肢体缺血标准血管内治疗的六年多中心经验
J Cardiovasc Surg (Torino). 2018 Oct;59(5):707-715. doi: 10.23736/S0021-9509.16.09737-8. Epub 2016 Nov 23.
4
Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.球囊血管成形术和选择性支架置入术治疗股浅动脉-腘动脉疾病的晚期结果相当。
J Vasc Surg. 2011 Oct;54(4):1051-1057.e1. doi: 10.1016/j.jvs.2011.03.283. Epub 2011 Jun 2.
5
Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia.主 everolimus 洗脱支架置入术与球囊血管成形术治疗长段下肢动脉病变致严重肢体缺血:单纯球囊血管成形术与补救性裸金属支架置入术的比较。
J Endovasc Ther. 2011 Feb;18(1):1-12. doi: 10.1583/10-3242.1.
6
Comparison of Atherectomy to Balloon Angioplasty and Stenting for Isolated Femoropopliteal Revascularization.斑块旋切术与球囊血管成形术及支架置入术用于孤立性股腘动脉血运重建的比较
Ann Vasc Surg. 2020 Nov;69:261-273. doi: 10.1016/j.avsg.2020.05.019. Epub 2020 Jun 6.
7
Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.药物涂层球囊在膝下血管成形术评估中的外周介入治疗(DEBATE-BTK):糖尿病合并严重肢体缺血患者的随机试验。
Circulation. 2013 Aug 6;128(6):615-21. doi: 10.1161/CIRCULATIONAHA.113.001811.
8
Below-The-Knee Angioplasty for Critical Limb Ischemia: Results of a Series of 157 Procedures and Impact of the Angiosome Concept.下肢血管成形术治疗严重肢体缺血:157例手术系列结果及血管区域概念的影响
Ann Vasc Surg. 2016 Oct;36:199-207. doi: 10.1016/j.avsg.2016.03.032. Epub 2016 Jul 15.
9
Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).原发性自膨式镍钛合金支架置入术与球囊血管成形术联合选择性补救性支架置入术治疗重度间歇性跛行或严重肢体缺血患者的腘下动脉疾病(EXPAND研究)
J Endovasc Ther. 2015 Oct;22(5):690-7. doi: 10.1177/1526602815598955. Epub 2015 Aug 5.
10
Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial.腘动脉治疗中支架置入术与球囊血管成形术的比较:一项前瞻性、多中心、随机试验的两年结果
J Endovasc Ther. 2015 Feb;22(1):22-7. doi: 10.1177/1526602814564386.

引用本文的文献

1
Atherectomy in the Treatment of Peripheral Arterial Disease-A Case Series to Demonstrate Preferable Indications with Good Outcomes and a Literature Review.斑块旋切术治疗外周动脉疾病——一个展示良好疗效的优选适应症的病例系列及文献综述
J Clin Med. 2025 Feb 21;14(5):1437. doi: 10.3390/jcm14051437.
2
Randomized clinical trial to compare the efficacy of self-expanding bare metal nitinol stent and balloon angioplasty alone for below-the-knee lesions following successful balloon angioplasty: 1-year clinical outcomes.经球囊血管成形术后成功治疗的膝下病变患者中比较自膨式裸金属镍钛诺支架和单纯球囊血管成形术疗效的随机临床试验:1 年临床结果。
PLoS One. 2023 Nov 13;18(11):e0294132. doi: 10.1371/journal.pone.0294132. eCollection 2023.

本文引用的文献

1
Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.紫杉醇涂层球囊在治疗严重肢体缺血的腘动脉以下动脉中的应用与死亡和截肢风险:一项随机对照试验的系统评价和荟萃分析。
J Vasc Interv Radiol. 2020 Feb;31(2):202-212. doi: 10.1016/j.jvir.2019.11.015. Epub 2020 Jan 15.
2
Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.紫杉醇涂层球囊和支架在下肢股腘动脉中的应用死亡风险:随机对照试验的系统评价和荟萃分析。
J Am Heart Assoc. 2018 Dec 18;7(24):e011245. doi: 10.1161/JAHA.118.011245.
3
Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.血管成形术与支架置入术治疗慢性肢体威胁性缺血的腘下动脉病变
Cochrane Database Syst Rev. 2018 Dec 8;12(12):CD009195. doi: 10.1002/14651858.CD009195.pub2.
4
3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia.OLIVE 注册研究的 3 年结果:一项对严重肢体缺血患者的前瞻性多中心研究:严重肢体缺血患者股浅动脉腔内治疗的前瞻性、多中心、3 年随访研究。
JACC Cardiovasc Interv. 2015 Sep;8(11):1493-1502. doi: 10.1016/j.jcin.2015.07.005.
5
Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.药物涂层球囊与标准球囊血管成形术治疗临界肢体缺血的腘动脉血运重建:来自 IN.PACT DEEP 随机试验的 12 个月结果。
J Am Coll Cardiol. 2014 Oct 14;64(15):1568-76. doi: 10.1016/j.jacc.2014.06.1198.
6
[Systematic review of primary stenting for arteriosclerotic occlusion in below-the-knee arteries].[膝下动脉粥样硬化闭塞症一期支架置入术的系统评价]
Zhonghua Yi Xue Za Zhi. 2014 Mar 25;94(11):821-7.
7
Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia.血管内优先治疗方法与适当选择的临界肢体缺血患者的无截肢生存率的降低无关。
J Vasc Surg. 2014 Feb;59(2):392-9. doi: 10.1016/j.jvs.2013.09.001. Epub 2013 Nov 1.
8
Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.药物涂层球囊在膝下血管成形术评估中的外周介入治疗(DEBATE-BTK):糖尿病合并严重肢体缺血患者的随机试验。
Circulation. 2013 Aug 6;128(6):615-21. doi: 10.1161/CIRCULATIONAHA.113.001811.
9
A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial.前瞻性随机多中心比较球囊血管成形术和雷帕霉素洗脱支架在缺血性外周动脉疾病患者中的应用:ACHILLES 试验 1 年结果。
J Am Coll Cardiol. 2012 Dec 4;60(22):2290-5. doi: 10.1016/j.jacc.2012.08.989.
10
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.随机比较依维莫司洗脱支架与裸金属支架在伴有严重肢体缺血和腘动脉以下动脉闭塞性疾病患者中的应用。
J Vasc Surg. 2012 Feb;55(2):390-8. doi: 10.1016/j.jvs.2011.07.099. Epub 2011 Dec 14.